Andrea S. James - 31 Oct 2025 Form 4/A - Amendment Insider Report for Insight Molecular Diagnostics Inc. (OCX)

Role
Chief Financial Officer
Signature
/s/ Andrea James
Issuer symbol
OCX
Transactions as of
31 Oct 2025
Net transactions value
-$73,172
Form type
4/A - Amendment
Filing time
13 Nov 2025, 16:34:13 UTC
Date Of Original Report
04 Nov 2025
Previous filing
30 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
James Andrea S. Chief Financial Officer C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE /s/ Andrea James 13 Nov 2025 0002027010

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMDX Common Stock Options Exercise $0 +50,000 +33% $0.000000 201,231 31 Oct 2025 Direct F1
transaction IMDX Common Stock Tax liability $73,172 -12,175 -6.1% $6.01 189,056 31 Oct 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMDX Restricted Stock Units Options Exercise $0 -50,000 -50% $0.000000 50,000 31 Oct 2025 Common Stock 50,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting an award of performance-based restricted stock units ("RSUs") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of common stock.
F2 The reported disposition reflects shares withheld by the Company to cover required tax withholding obligations upon the vesting of the RSUs. The reporting person did not sell any shares.
F3 The RSUs vested on the last day of the month upon satisfaction of the "Baby Shelf" performance condition described in the Reporting Person's Employment Agreement, which required that the Company's public float reach at least $75 million such that the Company would no longer be subject to the SEC's "baby shelf" limitations on Form S-3 eligibility. The satisfaction of this condition resulted in the vesting of 50% of the RSUs granted to the Reporting Person, subject to the Reporting Person's continued service.

Remarks:

This Form 4/A is being filed to amend the original Form 4 filed on November 4, 2025 which inadvertently did not report the withholding of 12,175 shares of common stock to cover tax withholding obligations upon the vesting of performance-based restricted stock units ("RSUs").